Literature DB >> 19920649

Hypotony following trabeculectomy.

S K Seah1, J A Prata, D S Minckler, G Baerveldt, P P Lee, D K Heuer.   

Abstract

OBJECTIVE: To determine the risk factors for development of postoperative hypotony and the effects of hypotony on the outcome of surgery in terms of intraocular pressure (IOP) control and final visual acuity in patients who underwent standard trabeculectomy, trabeculectomy with postoperative 5-fluorouracil injections, trabeculectomy with intraoperative mitomycin-C, or trabeculectomy with both antimetabolites. PATIENTS AND
DESIGN: We retrospectively reviewed the outcome in 155 eyes of 155 patients who underwent standard trabeculectomy (n = 15), trabeculectomy with postoperative 5-fluorouracil injections (n = 81), trabeculectomy with intraoperative mitomycin-C (n = 55), or trabeculectomy with both antimetabolites (n = 4).
RESULTS: Hypotony developed in 108 (69.6%) eyes (IOP < 6 mm Hg) at some point postoperatively; this was transient (< 14 days) in 75 eyes, and prolonged (> 14 days) in 33 eyes. The positive preoperative factors for the development of prolonged hypotony were young age, myopia, and preoperative use of carbonic anhydrase inhibitor. The mean age of patients in whom prolonged hypotony developed was 57.3 +/- 18.3 years (compare the mean age without prolonged hypotony, 65.3 +/- 14.5 years, p = 0.02). Sixteen of 33 (48%) patients in whom prolonged hypotony developed were myopic (p = 0.02), and 23 of 33 (70%) patients in whom prolonged hypotony developed used preoperative carbonic anhydrase inhibitor (p = 0.07).
CONCLUSIONS: There was no difference in the incidence of hypotony between patients who received 5-fluorouracil and those who received mitomycin-C. Postoperative hypotony was associated with three types of postoperative complications: shallow anterior chamber, choroidal detachment, and hypotony maculopathy (p = 0.02, 0.000, and 0.05, respectively). Hypotony did not have any effect on the success of surgery in terms of IOP control, but did have an effect on the visual outcome. Fourteen of the 33 patients (42.4%) in whom prolonged hypotony developed had worse visual acuity (p = 0.002); of these cases, four were due to hypotony maculopathy.

Entities:  

Year:  1995        PMID: 19920649

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  16 in total

1.  Effect of trabeculectomy on ocular and corneal higher order aberrations.

Authors:  Shima Fukuoka; Shiro Amano; Norihiko Honda; Tatsuya Mimura; Tomohiko Usui; Makoto Araie
Journal:  Jpn J Ophthalmol       Date:  2011-07-20       Impact factor: 2.447

2.  Anticipation, anti-glaucoma drug treatment response and phenotype of a Chinese family with glaucoma caused by the Pro370Leu myocilin mutation.

Authors:  Chun-Mei Li; Yue-Hong Zhang; Rong-Hua Ye; Chang-Xian Yi; Yi-Min Zhong; Dan Cao; Xing Liu
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

3.  Short-term change in higher-order aberrations after mitomycin-C-augmented trabeculectomy.

Authors:  Seong Ho Jo; Je Hyun Seo
Journal:  Int Ophthalmol       Date:  2017-12-22       Impact factor: 2.031

4.  Macular hole and sub-hyaloid hemorrhage following filtering surgery with mitomycin C.

Authors:  Parul Sony; Viney Gupta; Ramanjit Sihota
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-19       Impact factor: 3.117

5.  Evaluation the adjunctive use of combined bevacizumab and mitomycinc to trabeculectomy in management of recurrent pediatric glaucoma.

Authors:  R A Mahdy; S M Al-Mosallamy; M A Al-Aswad; A Bor'i; W M El-Haig
Journal:  Eye (Lond)       Date:  2015-10-02       Impact factor: 3.775

6.  Bleb revision for resolution of hypotony maculopathy following primary trabeculectomy.

Authors:  Elena Bitrian; Brian J Song; Joseph Caprioli
Journal:  Am J Ophthalmol       Date:  2014-05-27       Impact factor: 5.258

7.  Effect of excision of avascular bleb and advancement of adjacent conjunctiva for treatment of hypotony.

Authors:  Kyoungsook Lee; Sungmin Hyung
Journal:  Korean J Ophthalmol       Date:  2009-12-04

8.  Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy.

Authors:  Florentina Joyce Freiberg; Juliane Matlach; Franz Grehn; Sabine Karl; Thomas Klink
Journal:  Clin Ophthalmol       Date:  2013-06-20

9.  Risk factors for choroidal detachment after trabeculectomy with mitomycin C.

Authors:  Akira Haga; Masaru Inatani; Kohei Shobayashi; Sachi Kojima; Toshihiro Inoue; Hidenobu Tanihara
Journal:  Clin Ophthalmol       Date:  2013-07-11

10.  Anti-VEGF agents with or without antimetabolites in trabeculectomy for glaucoma: a meta-analysis.

Authors:  Qi Xiong; Zhiliang Li; Zhaohui Li; Yi Zhu; Sancar Abdulhalim; Ping Wang; Xiaojun Cai
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.